What is NDC 0832-7123?

0832-7123 is the product NDC for Divalproex Sodium, Divalproex sodium 250 mg/1 tablet, delayed release, listed with the FDA by Upsher-Smith Laboratories, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.

Upsher-Smith Laboratories, LLC, NDC labeler code 0832. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Divalproex Sodium?

185 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Divalproex Sodium NDC 0832-7123 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0832-7123Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00832-7123Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
0832-7123-01	0083271230100832712301	100 BLISTER PACK in 1 CARTON (0832-7123-01) / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0832-7123-89)Marketed from Apr 1, 2016
0832-7123-11	0083271231100832712311	100 TABLET, DELAYED RELEASE in 1 BOTTLE (0832-7123-11)Marketed from Mar 21, 2014
0832-7123-15	0083271231500832712315	500 TABLET, DELAYED RELEASE in 1 BOTTLE (0832-7123-15)Marketed from Mar 21, 2014

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Divalproex Sodium
Generic name (nonproprietary): divalproex sodium
Active ingredients: Divalproex sodium — 250 mg/1
Dosage form: Tablet, Delayed release
Route: Oral
Labeler: Upsher-Smith Laboratories, LLCNDC labeler code 0832
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078182
Marketing start: Mar 21, 2014
Marketing end: Oct 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 0832-7123_45afcbe0-c2e7-008a-e063-6394a90a111eSPL ID 45afcbe0-c2e7-008a-e063-6394a90a111eSPL set ID 02304a23-4a5f-47bc-9687-4044b43f7a20RxCUI 1099625, 1099678, 1099870UNII 644VL95AO6
Pharmacologic class: Anti-epileptic Agent; Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400832712301 followed by a unit qualifier and the quantity

Package 00832-7123-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 11, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Divalproex sodium delayed-release tablets are an anti-epileptic drug indicated for: Treatment of manic episodes associated with bipolar disorder ( 1.1 ) Monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures ( 1.2 ) Prophylaxis of migraine headaches ( 1.3 ) 1.1 Mania Divalproex sodium is a valproate and is indicated for the treatment of the manic episodes associated with bipolar disorder. A manic episode is a distinct period of abnormally and persistently elevated, expansive, or irritable mood. Typical symptoms of mania include pressure of speech, motor hy…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0832-7123

What is NDC 0832-7123?: 0832-7123 is the product NDC for Divalproex Sodium, Divalproex sodium 250 mg/1 tablet, delayed release, listed with the FDA by Upsher-Smith Laboratories, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Divalproex Sodium.
What is the active ingredient?: Divalproex sodium.
Who is the labeler?: Upsher-Smith Laboratories, LLC, NDC labeler code 0832. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Divalproex Sodium?: 185 other product NDCs are listed under this name. See all Divalproex Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Divalproex Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
divalproex sodium	Divalproex sodium 250 mg/1	Tablet, Film coated, Extended releaseOral	Coupler LLC	67046-1696	67046-1696-03
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Delayed releaseOral	Cardinal Health 107, LLC	55154-0577	55154-0577-00
divalproex sodium	Divalproex sodium 500 mg/1	Tablet, Film coated, Extended releaseOral	Preferred Pharmaceuticals Inc.	68788-4193	68788-4193-0368788-4193-0668788-4193-09
divalproex sodium	Divalproex sodium 250 mg/1	Tablet, Delayed releaseOral	Coupler LLC	67046-1683	67046-1683-03
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Delayed releaseOral	Unit Dose Solutions, Inc.	87441-027	87441-0027-01
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Delayed releaseOral	Unit Dose Solutions, Inc.	87441-028	87441-0028-01
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-2021	67046-2021-03
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Extended releaseOral	Preferred Pharmaceuticals Inc.	68788-4100	68788-4100-0368788-4100-0668788-4100-09
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Film coated, Extended releaseOral	Safecor Health, LLC	48433-033	48433-0033-08
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Film coated, Extended releaseOral	Safecor Health, LLC	48433-034	48433-0034-08

All 186 Divalproex Sodium NDCs

Other NDCs under ANDA 078182

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078182
Product	Strength	Form · route	Labeler	Product NDC
Divalproex Sodium	Divalproex sodium 125 mg/1	Tablet, Delayed releaseOral	Upsher-Smith Laboratories, LLC	0832-7122
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Delayed releaseOral	Upsher-Smith Laboratories, LLC	0832-7124
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Delayed releaseOral	Cardinal Health 107, LLC	55154-5633
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Delayed releaseOral	Aphena Pharma Solutions - Tennessee, LLC	71610-031
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Delayed releaseOral	Aphena Pharma Solutions - Tennessee, LLC	71610-032